In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system

Cancer Gene Therapy

Volumn 6, Issue 2, 1999, Pages 139-146

  Pitzer, Claudia ^a   Schindowski, Katharina ^a   Pomer, Sigmund ^b   Wirth, Thomas ^c   Zöller, Margot ^a,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Laboratory of Molecular Oncology   (Germany)

^d UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Gene therapy; Interleukin 2 gene; Tetracycline; Tumor vaccines

Indexed keywords

INTERLEUKIN 2; LUCIFERASE; TETRACYCLINE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL CULTURE; CELL STRAIN 3T3; DOSE RESPONSE; GENE THERAPY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN; MELANOMA; METABOLISM; METHODOLOGY; MOUSE; NEOPLASM; NUDE MOUSE; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

3T3 CELLS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE THERAPY; HELA CELLS; HUMANS; INTERLEUKIN-2; LUCIFERASES; MELANOMA; MICE; MICE, NUDE; MODELS, GENETIC; NEOPLASMS; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRACYCLINE; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033088239     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700021     Document Type: Article

References (25)

1. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA. 1992;89:5547-5551.
2. Damke H, Gossen M, Freundlieb S, et al. Tightly regulated and inducible expression of dominant interfering dynamin mutant in stably transformed HeLa cells. Methods Enzymol 1995;257:209-220.
3. Wang L, Takagaki Y, Manley JL. Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability. Genes Dev. 1996;10:2588-2599.
4. Hwang JJ, Scuric Z, Anderson F. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system. J Virol. 1996;70:8138-8141.
5. Schultze N, Burki Y, Lang Y, et al. Efficient control of gene expression by single integration of the tetracycline system in transgenic mice. Nat Biotechnol. 1996;14:499-503.
6. Fruh K, Gossen M, Wang K, et al. Displacement of housekeeping proteosome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J. 1994;13:3236-3244.
7. Furth PA, Onge SL, Böger H, et al. Temporal control of gene expression in transgenic mice by tetracycline-responsive promoter. Proc Natl Acad Sci USA. 1994;91:9302-9306.
8. Passman RS, Fishman GI. Regulated expression of foreign genes in vivo after germline transfer. J Clin Invest. 1994; 94:2421-2425.
9. Efrat S, Fuscodemane D, Lemberg H, et al. Conditional transformation of a pancreatic β cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA. 1995;92:3576-3580.
10. Kistner A, Gossen M, Zimmerman F, et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA. 1996;93:10933-10938.
11. Baron U, Freundlich S, Gossen M, Bujard H. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Adds Res. 1995;23:3605-3606.
12. Maxwell IH, Spitzer AL, Long CJ, et al. Autonomous parvovirus transduction of a gene under control of tissue-specific or inducible promoters. Gene Ther. 1996; 3:28-36.
13. Gansbacher B, Zier K, Daniels B, et al. Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med. 1990;172:1217-1224.
14. Tsai S-CJ, Gansbacher B, Tait L, et al. Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts. J Natl Cancer Inst. 1993;85:546-553.
15. Zier KS, Salvadori S, Cronin KC, Gansbacher B. Vaccination with IL-2-secreting tumor cells stimulates the generation of IL-2 responsive T-cells and prevents the development of unresponsiveness. Cancer Gene Ther. 1994;1: 43-50.
16. Fearon E, Pardoll D, Itaya T, et al. Interleukin 2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell. 1990;60:397-403.
17. Abdel-Wahab Z, Li W-P, Osanto S, et al. Transduction of human melanoma cells with interleukin-2 gene reduced tumorigenicity and enhances host antitumor immunity: a nude mouse model. Cell Immunol. 1994;159:26-39.
18. Bean MA, Bloom BR, Herberman RB, et al. Cell-mediated cytotoxicity for bladder carcinoma. Cancer Res. 1975; 35:2902-2913.
19. Pear W, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA. 1993;90:8392-8396.
20. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd Ed. Plainview, New York: Cold-Spring Harbor Laboratory Press.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
22. Matzku S, Schuhmacher J, Kirchgeßner H, Brüggen J. Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Eur J Nucl Med. 1986;12:405-412.
23. Fakhrai H, Shawler DL, Gjerset R, et al. Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity. Hum Gene Ther. 1995;6:591-601.
24. Dhawan J, Rando TA, Elson S, et al. Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle. Somat Cell Mol Genet. 1995;21: 233-240.
25. Fishman GI, Kaplan ML, Buttrick PM. Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest. 1994;93:1864-1868.